A flurry of recent activity has meant that almost $1.5bn has been raised from initial public offerings (IPOs) by medtech companies so far in 2020. After a very quiet three months as equity markets plummeted due to the pandemic, it seems IPOs are back in favour in the medtech sector (see table).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?